Buparlisib in combination with tamoxifen in pretreated patients with hormone receptorâpositive, HER2ânegative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression
Welt, Anja, Wiesweg, Marcel, Theurer, Sarah, Abenhardt, Wolfgang, Groschek, Matthias, Müller, Lothar, Schröder, Jan, Tewes, Mitra, Chiabudini, Marco, Potthoff, Karin, Bankfalvi, Agnes, Marschner, NoЖурнал:
Cancer Medicine
DOI:
10.1002/cam4.3092
Date:
April, 2020
Файл:
PDF, 459 KB
2020
File converter
Більше результатів пошуку
More benefits 
